Retour
Fourchette du Jour
6,85 €
7,33 €
Fourchette 52 Semaines
2,41 €
8,72 €
Volume
793 521
Moyenne 50J / 200J
6,41 €
/
5,73 €
Clôture Précédente
6,68 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,2 | 0,3 |
| P/B | 3,1 | 3,0 |
| ROE % | -109,9 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
12,50 €
+72.9%
Low: 9,00 €
High: 16,00 €
BPA Prévisionnel
-1,73 €
CA Est.
3,68M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,17 €
1,17 € – 1,17 €
|
456,29M | 2 |
| FY2029 |
0,15 €
0,15 € – 0,15 €
|
279,56M | 4 |
| FY2028 |
-0,96 €
-1,48 € – -0,39 €
|
107,00M | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-19 | -0,52 € | -0,50 € | +3,6% |
| 2025-11-03 | -0,42 € | -0,48 € | -14,3% |
| 2025-08-12 | -0,51 € | -0,42 € | +17,6% |
| 2025-05-15 | -0,53 € | -0,59 € | -11,3% |
| 2025-03-06 | -0,79 € | -0,89 € | -12,7% |
| 2024-11-06 | -0,67 € | -0,79 € | -17,9% |
| 2024-08-13 | -0,68 € | -0,61 € | +10,3% |
| 2024-05-15 | -0,57 € | -0,64 € | -12,3% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -157,44M
PEG of 0,08 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-109,90%
ROIC-66,81%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,12
Current Ratio6,14
Interest Coverage0,00
Valorisation
P/E Ratio
-3,23
Forward P/EN/A
P/B Ratio3,13
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -174,33M |
| ROE | -109,90% | ROA | -74,97% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -157,44M |
| ROIC | -66,81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 6,14 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,23 | Forward P/E | N/A |
| P/B Ratio | 3,13 | P/S Ratio | N/A |
| PEG Ratio | 0,08 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 712,71 |
| Forward P/S | 153,07 | Fwd Earnings Yield | N/A |
| FCF Yield | -27,95% | ||
| Market Cap | 563,29M | Enterprise Value | 524,55M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 8,09M | 13,62M |
| Net Income | -174,33M | -124,70M | -96,02M | -85,98M | -72,19M |
| EPS (Diluted) | -1,99 | -3,06 | -4,83 | -10,10 | -10,14 |
| Gross Profit | -1,64M | -2,46M | -2,58M | 8,09M | 13,62M |
| Operating Income | -179,21M | -129,73M | -104,32M | -106,45M | -72,25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 232,54M | 188,66M | 164,94M | 260,25M | 232,38M |
| Total Liabilities | 52,53M | 51,42M | 38,46M | 48,59M | 24,17M |
| Shareholders' Equity | 180,01M | 137,25M | 126,48M | 211,67M | 208,21M |
| Total Debt | 21,16M | 24,18M | 26,27M | 28,55M | 2,06M |
| Cash & Equivalents | 59,90M | 80,24M | 74,02M | 155,38M | 119,14M |
| Current Assets | 205,46M | 157,30M | 129,73M | 219,64M | 222,61M |
| Current Liabilities | 33,47M | 30,26M | 14,52M | 22,51M | 23,60M |